<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>12</volume><submitter>Wang CL</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4>The fungus of Ganoderma is a traditional medicine in Asia with a variety of pharmacological functions including anti-cancer activities. We have purified an extracellular heteropolysaccharide fraction, PS-F2, from the submerged mycelia culture of G. formosanum and shown that PS-F2 exhibits immunostimulatory activities. In this study, we investigated the molecular mechanisms of immunostimulation by PS-F2.&lt;h4>Results&lt;/h4>PS-F2-stimulated TNF-α production in macrophages was significantly reduced in the presence of blocking antibodies for Dectin-1 and complement receptor 3 (CR3), laminarin, or piceatannol (a spleen tyrosine kinase inhibitor), suggesting that PS-F2 recognition by macrophages is mediated by Dectin-1 and CR3 receptors. In addition, the stimulatory effect of PS-F2 was attenuated in the bone marrow-derived macrophages from C3H/HeJ mice which lack functional Toll-like receptor 4 (TLR4). PS-F2 stimulation triggered the phosphorylation of mitogen-activated protein kinases JNK, p38, and ERK, as well as the nuclear translocation of NF-κB, which all played essential roles in activating TNF-α expression.&lt;h4>Conclusions&lt;/h4>Our results indicate that the extracellular polysaccharides produced by G. formosanum stimulate macrophages via the engagement of multiple pattern-recognition receptors including Dectin-1, CR3 and TLR4, resulting in the activation of Syk, JNK, p38, ERK, and NK-κB and the production of TNF-α.</pubmed_abstract><journal>BMC complementary and alternative medicine</journal><pagination>119</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC3495220</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Extracellular polysaccharides produced by Ganoderma formosanum stimulate macrophage activation via multiple pattern-recognition receptors.</pubmed_title><pmcid>PMC3495220</pmcid><pubmed_authors>Pi CC</pubmed_authors><pubmed_authors>Chen CJ</pubmed_authors><pubmed_authors>Liu WH</pubmed_authors><pubmed_authors>Wang CL</pubmed_authors><pubmed_authors>Lu CY</pubmed_authors><pubmed_authors>Chu CL</pubmed_authors><pubmed_authors>Zhuang YJ</pubmed_authors></additional><is_claimable>false</is_claimable><name>Extracellular polysaccharides produced by Ganoderma formosanum stimulate macrophage activation via multiple pattern-recognition receptors.</name><description>&lt;h4>Background&lt;/h4>The fungus of Ganoderma is a traditional medicine in Asia with a variety of pharmacological functions including anti-cancer activities. We have purified an extracellular heteropolysaccharide fraction, PS-F2, from the submerged mycelia culture of G. formosanum and shown that PS-F2 exhibits immunostimulatory activities. In this study, we investigated the molecular mechanisms of immunostimulation by PS-F2.&lt;h4>Results&lt;/h4>PS-F2-stimulated TNF-α production in macrophages was significantly reduced in the presence of blocking antibodies for Dectin-1 and complement receptor 3 (CR3), laminarin, or piceatannol (a spleen tyrosine kinase inhibitor), suggesting that PS-F2 recognition by macrophages is mediated by Dectin-1 and CR3 receptors. In addition, the stimulatory effect of PS-F2 was attenuated in the bone marrow-derived macrophages from C3H/HeJ mice which lack functional Toll-like receptor 4 (TLR4). PS-F2 stimulation triggered the phosphorylation of mitogen-activated protein kinases JNK, p38, and ERK, as well as the nuclear translocation of NF-κB, which all played essential roles in activating TNF-α expression.&lt;h4>Conclusions&lt;/h4>Our results indicate that the extracellular polysaccharides produced by G. formosanum stimulate macrophages via the engagement of multiple pattern-recognition receptors including Dectin-1, CR3 and TLR4, resulting in the activation of Syk, JNK, p38, ERK, and NK-κB and the production of TNF-α.</description><dates><release>2012-01-01T00:00:00Z</release><publication>2012 Aug</publication><modification>2024-11-20T02:20:01.795Z</modification><creation>2019-03-27T01:00:20Z</creation></dates><accession>S-EPMC3495220</accession><cross_references><pubmed>22883599</pubmed><doi>10.1186/1472-6882-12-119</doi></cross_references></HashMap>